Health Score

0 Good

Metadata coverage

Abstract

ORCID

References

License

Extended metadata coverage

Informational — signals of interoperability and funding across the corpus. Not part of the health score.

Funding

Funder

Award / grant

Affiliation & institutional identifiers

Affiliation

ROR ID

Update policy

Your prioritized action plan

Ordered by how many DOIs each fix touches — start here, not with every error at once.

Attach ORCID iDs across 901 articles

ORCID iDs strengthen author disambiguation and institutional reporting.

High impact901 DOIs

Deposit reference lists for 787 records

Deposited references power Crossref's Cited-by links between your articles and the literature.

Medium impact787 DOIs

Add abstracts to 492 articles

Abstracts are what surface your work in Google Scholar, Dimensions, and OpenAlex.

Medium impact492 DOIs

DOIs for this ISSN

Showing the top 5 of 1639 DOIs, ordered by correction priority.

#	Title	Missing	Priority	Citations
1	Burden of rheumatoid arthritis among US Medicare population:… (10.1093/rap/rky005)	Abstract ORCID	82.17	43
2	Circulating PD-1+CXCR5−CD4+ T cells underlying the immunolog… (10.1093/rap/rky043)	Abstract ORCID	76.57	33
3	An exploration of the experience of pain among culturally di… (10.1093/rap/rkx002)	Abstract ORCID	75.93	32
4	Risk factors for the development of systemic sclerosis: a sy… (10.1093/rap/rky041)	Abstract ORCID	71.57	26
5	Distinctive clinical phenotype of anti-centromere antibody-p… (10.1093/rap/rky002)	Abstract ORCID	69.90	24
6	Efficacy and safety of anakinra for undifferentiated autoinf… (10.1093/rap/rkz004)	Abstract ORCID	68.09	22
7	An observational multicentre study on the efficacy and safet… (10.1093/rap/rkz005)	Abstract ORCID	65.05	19
8	Primary care challenges in diagnosing and referring patients… (10.1093/rap/rky012)	Abstract ORCID	63.94	18
9	Predicting disease progression and poor outcomes in patients… (10.1093/rap/rkz002)	Abstract ORCID	63.94	18
10	47. Activated PI3 kinase delta syndrome: a rare cause of inf… (10.1093/rap/rky034.010)	Abstract References ORCID	63.38	6
11	Long-term effectiveness of tumour necrosis factor-α inhibito… (10.1093/rap/rky042)	Abstract ORCID	60.21	15
12	Clinical features of macrophage activation syndrome as the o… (10.1093/rap/rkz013)	Abstract ORCID	60.21	15
13	Successful treatment of hip involvement in SAPHO syndrome wi… (10.1093/rap/rkac084)	Abstract References ORCID	58.36	5
14	Altered cytokine expression by macrophages from HLA-B27-posi… (10.1093/rap/rky014)	Abstract ORCID	57.31	13
15	Interleukin-6 does not upregulate pro-inflammatory cytokine… (10.1093/rap/rkz011)	Abstract ORCID	57.31	13
16	The perspective of patients with early rheumatoid arthritis… (10.1093/rap/rkz035)	References ORCID	53.96	11
17	Applied machine learning and artificial intelligence in rheu… (10.1093/rap/rkaa005)	ORCID	53.10	132
18	Correction to: The diagnosis and management of systemic auto… (10.1093/rap/rkae085)	Abstract References ORCID	52.42	4
19	23. An adverse neuropsychiatric reaction following treatment… (10.1093/rap/rky033.014)	Abstract References ORCID	52.42	4
20	EP15 A self-limiting symmetrical polyarthritis following COV… (10.1093/rap/rkaa052.014)	References ORCID	50.00	9
21	Anti-EJ, anti-MDA5 double-positive chronic clinically amyopa… (10.1093/rap/rky022)	Abstract ORCID	50.00	9
22	Retroperitoneal fibrosis; a single-centre case experience wi… (10.1093/rap/rky050)	Abstract ORCID	50.00	9
23	Efficacy and safety of subcutaneous tocilizumab in rheumatoi… (10.1093/rap/rkz010)	Abstract ORCID	50.00	9
24	The perspective of people with axial spondyloarthritis regar… (10.1093/rap/rkz043)	References ORCID	50.00	9
25	EP01 Post COVID-19 reactive arthritis (10.1093/rap/rkaa052)	References ORCID	47.71	8
26	Successful treatment with the IL12/IL23 antagonist ustekinum… (10.1093/rap/rkaa082)	Abstract ORCID	47.71	8
27	<b>Cutaneous vasculitis after severe acute respiratory syndr… (10.1093/rap/rkab050)	Abstract ORCID	47.71	8
28	Catastrophic antiphospholipid syndrome complicated with esse… (10.1093/rap/rkab096)	Abstract ORCID	47.71	8
29	Hypertrophic pulmonary osteoarthropathy: an unusual presenta… (10.1093/rap/rky009)	Abstract ORCID	47.71	8
30	Exploring the illness representations of people with psoriat… (10.1093/rap/rky023)	Abstract ORCID	47.71	8
31	Retrospective single-centre analysis of IgG4-related disease… (10.1093/rap/rkz014)	Abstract ORCID	47.71	8
32	Hydroxychloroquine and QT prolongation: reassuring data in a… (10.1093/rap/rkaa044)	Abstract ORCID	45.15	7
33	What does evidence-based medicine tell us about treatments f… (10.1093/rap/rkx019)	Abstract ORCID	45.15	7
34	Successful use of adalimumab in immune checkpoint inhibitor-… (10.1093/rap/rky001)	Abstract ORCID	45.15	7
35	Prospective associations between illness perceptions and hea… (10.1093/rap/rky007)	Abstract ORCID	45.15	7
36	Outcomes and compliance with standards of care in anti-neutr… (10.1093/rap/rky025)	Abstract ORCID	45.15	7
37	8. False positive mumps serology in a patient with cerebral… (10.1093/rap/rky033)	Abstract References ORCID	45.15	3
38	16. A rare case of CNS demyelination with anti-TNF treatment (10.1093/rap/rky033.008)	Abstract References ORCID	45.15	3
39	Defining new clinically derived criteria for high disease ac… (10.1093/rap/rky044)	Abstract ORCID	45.15	7
40	Impact of caring for someone with a rare rheumatic condition… (10.1093/rap/rkz003)	Abstract ORCID	45.15	7
41	Is it me? The impact of patient–physician interactions on lu… (10.1093/rap/rkaa037)	ORCID	43.31	53
42	An investigation of contextual factors in the application of… (10.1093/rap/rky019)	Abstract ORCID	42.25	6
43	What moves the rheumatologist? Unravelling decision making i… (10.1093/rap/rky027)	Abstract ORCID	42.25	6
44	Tocilizumab-induced drug reaction with eosinophilia and syst… (10.1093/rap/rky029)	Abstract ORCID	42.25	6
45	Fucosidosis mimicking juvenile idiopathic arthritis (10.1093/rap/rky040)	Abstract ORCID	42.25	6
46	Good efficacy achieved by telitacicept, corticosteroids and… (10.1093/rap/rkad088)	Abstract ORCID	38.91	5
47	22. Hereditary Haemochromatosis presented as a case of early… (10.1093/rap/rkx010.004)	Abstract References ORCID	35.78	2
48	65. Blau syndrome treated with sequential biologics (10.1093/rap/rky034.028)	Abstract References ORCID	35.78	2
49	86. Intravenous anakinra treatment in a rare case of macroph… (10.1093/rap/rky034.049)	Abstract References ORCID	35.78	2
50	Severe destructive arthritis in adult-onset Still’s disease (10.1093/rap/rky052)	Abstract References ORCID	35.78	2